Long-term use of nonsteroidal anti-inflammatory drugs for pain control in patients with osteoarthritis: results of the 12-month observational study AELITA (Analgesia: Effective Treatment Using The Therapeutic Algorithm)
Open Access
- 15 December 2021
- journal article
- research article
- Published by IMA Press, LLC in Modern Rheumatology Journal
- Vol. 15 (6) , 84-90
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are the primary means of managing chronic osteoarthritis (OA) pain. The choice of NSAIDs is based on an analysis of the risk of adverse reactions (ARs). Objective: to evaluate the efficacy and safety of long-term use of NSAIDs for pain control in patients with OA in real clinical practice.Patients and methods. To assess the results of long-term use of NSAIDs in OA, a 12-month observational non-interventional study was conducted. It included 611 patients with knee, hip and generalized OA, and nonspecific back pain associated with OA of the facet joints. All patients were prescribed aceclofenac (Aertal®) 200 mg/day. The patients' condition was assessed 2 weeks, 3, 6, 9 and 12 months after the start of therapy. The following parameters were determined: the intensity of pain during movement and the general health assessment (GA) according to the visual analogue scale (VAS, 10 cm); pain intensity according to the Likert verbal rating scale (VRS) (0–4); the number of patients with a pain reduction of ≥50% from baseline; patients' assessment of the result of therapy according to Likert VRS (1–5). The development of ARs was recorded at each visit.Results and discussion. By month 12, 46.8% of patients had dropped out of observation. In patients who continued the study, the average severity of pain according to the VAS at baseline, after 2 weeks, 3, 6, 9 and 12 months was: 6.5±1.2; 4.8±1.4; 3.2±1.4; 2.6±1.4; 2.2±1.1; 1.4±1.1 cm, respectively (significant differences compared to the baseline for all points – pConclusion. Aceclofenac is an effective and relatively safe drug for the long-term management of chronic pain in OA.Keywords
This publication has 18 references indexed in Scilit:
- Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: prescribe or proscribe?Therapeutic Advances in Musculoskeletal Disease, 2021
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and KneeArthritis & Rheumatology, 2020
- OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritisOsteoarthritis and Cartilage, 2019
- Treat-to-target strategy for knee osteoarthritis. International technical expert panel consensus and good clinical practice statementsTherapeutic Advances in Musculoskeletal Disease, 2019
- Trajectories and risk profiles of pain in persons with radiographic, symptomatic knee osteoarthritis: data from the osteoarthritis initiativeOsteoarthritis and Cartilage, 2014
- Individual NSAIDs and Upper Gastrointestinal ComplicationsDrug Safety, 2012
- Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritisAnnals of the Rheumatic Diseases, 2007
- Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparisonThe Lancet, 2006
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- A Multicentre Study of Tenoxicam for the Treatment of Osteo-Arthritis and Rheumatoid Arthritis in General PracticeJournal of International Medical Research, 1990